Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
Awards, Grants & Initiatives
New and exciting opportunities allow us to address previously unmet patient needs and these continue to drive us each day.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
CSL partnered with industry and advocacy organizations in Germany to create a bold, visual demonstration of why primary immun…
HEMGENIX® for patients with severe and moderate Hemophilia B now available in Germany
Access for All: Prevention of bleeds as the global standard of care
This year’s Alpha1 Science Awards winners announced at the Annual Meeting of the German Respiratory Society
With our sustainable strategy in our Early Career Programs, we attract and develop potential future leaders for CSL Behring.
The new base fractionation in Marburg starts regular operation with a ceremonial opening.
Marburg's St. Elizabeth’s Church was lit up with homemade green energy on Rare Disease Day
CSL Special Award "Health" of the Marburg Idea Competition goes to Team HAPPY
Approval of HEMGENIX® underscores CSL’s promise to deliver life-changing innovations that have the potential to help patients…
Americas
Asia Pacific
Middle East
Europe
